Malcova is redefining breast cancer imaging through three core innovations: our scatter-free Narrow-Beam CT, life-like digital and physical twins, and intelligent AI-powered software. Together, these technologies offer greater clarity, earlier detection, and better outcomes—while minimizing radiation and maximizing comfort.
Malcova’s patented Narrow-Beam CT redefines what’s possible in breast imaging. Unlike traditional systems that rely on painful compression and produce scatter-contaminated images, our novel approach delivers crystal-clear, 3D imaging—free from distortion and at a fraction of the radiation dose.
Backed by peer-reviewed research, our platform was the first to reveal the true extent of scatter contamination in breast CT. We responded with a breakthrough scanning method that virtually eliminates scatter, enabling earlier, safer, and more confident detection of disease.
Our digital twins are high-fidelity, computer-based models that simulate real breast tissue morphology and behavior—offering limitless, bias-controllable training data. Our physical twins are realistic, scan-ready phantoms derived from actual patient images, enabling repeatable imaging and AI training without radiation risk.
Together, these technologies accelerate AI advancements, reduce clinical trial dependencies, and empower healthcare providers with unmatched diagnostic precision.
By combining physical realism with digital precision, our technologies fast-track AI development, minimize reliance on human trials, and equip clinicians with sharper, more confident diagnoses.
We capture multiple data points at each tissue site, delivering deeper diagnostic clarity and enhanced AI training power.
Our compact, free-moving system eliminates bulky, restrictive equipment—providing flexibility in clinical settings and comfort for patients.
Whether scanning smaller or denser breasts, our platform adapts to variations in tissue type and breast diameter—producing consistent, high-quality images across the board.
Malcova’s breakthrough imaging platform is built on years of rigorous research. Our findings on scatter contamination and 3D CT imaging have been published in leading scientific journals, setting new standards in the breast cancer imaging field.